Lindbrook Capital, LLC Spring Works Therapeutics, Inc. Transaction History
Lindbrook Capital, LLC
- $1.06 Billion
- Q1 2025
A detailed history of Lindbrook Capital, LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 246 shares of SWTX stock, worth $11,434. This represents 0.0% of its overall portfolio holdings.
Number of Shares
246
Previous 140
75.71%
Holding current value
$11,434
Previous $5,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding SWTX
# of Institutions
361Shares Held
63.1MCall Options Held
5.81MPut Options Held
2.55M-
Vanguard Group Inc Valley Forge, PA7.08MShares$329 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$261 Million0.0% of portfolio
-
State Street Corp Boston, MA2.92MShares$136 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.58MShares$120 Million0.01% of portfolio
-
Woodline Partners LP San Francisco, CA2.14MShares$99.7 Million0.66% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.9B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...